News
|
Tenders
Request for quotation – RFQZ79/5914/1 – Bioequivalence study: Empagliflozinum, 25 mg, coated tablets
In connection with the implementation of project 2022/ABM/04/00014-00 – “Development and advancement of a medicinal product with the active substance EMPAGLIFLOZIN – a generic drug for type 2…
Read more